Metabolomics in diabetes research (Q26822794)

language of work or name

1 reference

October 2012

1 reference

published in

Journal of Endocrinology

1 reference

volume

215

1 reference

issue

1

1 reference

page(s)

29-42

1 reference

Improved glycemic control with colesevelam treatment in patients with type 2 diabetes is not directly associated with changes in bile acid metabolism

cites work

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

NMR studies of body fluids

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Metabolomics: current technologies and future trends.

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

A metabonomic analysis of plasma from Zucker rat strains using gas chromatography/mass spectrometry and pattern recognition.

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Metabolism of glycerol in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Plasma and urine free L-carnitine in human diabetes mellitus

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris Prospective Study.

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Metabonomics studies of intact hepatic and renal cortical tissues from diabetic db/db mice using high-resolution magic-angle spinning 1H NMR spectroscopy

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

1H-nuclear magnetic resonance spectroscopy-based metabolic assessment in a rat model of obesity induced by a high-fat diet.

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Metabonomic fingerprints of fasting plasma and spot urine reveal human pre-diabetic metabolic traits

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Bile acid metabolism and the pathogenesis of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Correlative and quantitative 1H NMR-based metabolomics reveals specific metabolic pathway disturbances in diabetic rats

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry for metabonomics: Biomarker discovery for diabetes mellitus

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Simultaneously quantitative measurement of comprehensive profiles of esterified and non-esterified fatty acid in plasma of type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Bile acid signaling after an oral glucose tolerance test

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Plasma fatty acid metabolic profiling and biomarkers of type 2 diabetes mellitus based on GC/MS and PLS-LDA

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Opening up the "Black Box": metabolic phenotyping and metabolome-wide association studies in epidemiology

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

A combined (1)H NMR and HPLC-MS-based metabonomic study of urine from obese (fa/fa) Zucker and normal Wistar-derived rats

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Time-dependent changes in the plasma amino acid concentration in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Systematic functional analysis of the yeast genome

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Cross-platform comparison of methods for quantitative metabolomics of primary metabolism

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Analytical strategies in metabonomics

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Metabolomic analysis of livers and serum from high-fat diet induced obese mice

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

An amino acid profile to predict diabetes?

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Metabolite profiles and the risk of developing diabetes

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Metabolomics as a tool for cardiac research

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Understanding type 1 diabetes through genetics: advances and prospects

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Gut microorganisms, mammalian metabolism and personalized health care

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity.

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Endocrine functions of bile acids

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Measuring the metabolome: current analytical technologies

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

The metabonomics of aging and development in the rat: an investigation into the effect of age on the profile of endogenous metabolites in the urine of male rats using 1H NMR and HPLC-TOF MS

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

A multi-analytical platform approach to the metabonomic analysis of plasma from normal and Zucker (fa/fa) obese rats

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

The comparative metabonomics of age-related changes in the urinary composition of male Wistar-derived and Zucker (fa/fa) obese rats

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Multi-platform investigation of the metabolome in a leptin receptor defective murine model of type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Beyond glucose: metabolic shifts in responses to the effects of the oral glucose tolerance test and the high-fructose diet in rats.

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Proton-nuclear-magnetic-resonance studies of serum, plasma and urine from fasting normal and diabetic subjects

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Plasma free fatty acid concentrations in obesity.

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Plasma Amino Acid Levels and Insulin Secretion in Obesity

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Clinical risk factors, DNA variants, and the development of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Genotype score in addition to common risk factors for prediction of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Metabolomics reveals attenuation of the SLC6A20 kidney transporter in nonhuman primate and mouse models of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Glucose and insulin induction of bile acid synthesis: mechanisms and implication in diabetes and obesity

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Insulin regulation of cholesterol 7alpha-hydroxylase expression in human hepatocytes: roles of forkhead box O1 and sterol regulatory element-binding protein 1c.

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Free fatty acids and insulin resistance

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Obesity, insulin resistance and free fatty acids

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Genetics of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Genetics of type 2 diabetes: pathophysiologic and clinical relevance

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Development and application of rodent models for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Metabolomic profiling of dietary-induced insulin resistance in the high fat-fed C57BL/6J mouse.

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Colestilan monotherapy significantly improves glycaemic control and LDL cholesterol levels in patients with type 2 diabetes: a randomized double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Differentiating short- and long-term effects of diet in the obese mouse using (1) H-nuclear magnetic resonance metabolomics

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

The importance of free fatty acids in the development of Type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Metabonomics in pharmaceutical R&D.

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Effect of slow growth on metabolism of Escherichia coli, as revealed by global metabolite pool ("metabolome") analysis

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at?

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Role of bile acids and bile acid receptors in metabolic regulation

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

THE METABOLISM OF AMINO ACIDS IN DIABETES MELLITUS.

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Stimulation of insulin secretion by amino acids

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Influence of body fat distribution on free fatty acid metabolism in obesity

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Bidirectional modulation of insulin action by amino acids

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Glucose stimulates cholesterol 7alpha-hydroxylase gene transcription in human hepatocytes

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Secretion of insulin induced by amino acids and glucose in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Early hepatic insulin resistance in mice: a metabolomics analysis

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Blood glucose-lowering activity of colestimide in patients with type 2 diabetes and hypercholesterolemia: a case-control study comparing colestimide with acarbose

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Phylometabonomic patterns of adaptation to high fat diet feeding in inbred mice

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Thirty-one novel biomarkers as predictors for clinically incident diabetes

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Metabolomics and cardiovascular biomarker discovery

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Role of the gut microbiota in defining human health

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Acute lowering of plasma fatty acids lowers basal insulin secretion in diabetic and nondiabetic subjects

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects.

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Mechanism of amino acid-induced skeletal muscle insulin resistance in humans

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Fasting plasma free fatty acids and risk of type 2 diabetes: the atherosclerosis risk in communities study

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Cholestyramine therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. A short-term, double-blind, crossover trial.

1 reference

https://api.crossref.org/works/10.1530%2FJOE-12-0120

7 January 2021

Identifiers

DOI

10.1530/JOE-12-0120

1 reference

Consolidated OpenCitations Corpus – April 2017

1618722

1618722

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference